These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 11051298)

  • 21. A case of sporadic Creutzfeldt-Jakob disease with a Gerstmann-Sträussler-Scheinker phenotype but no alterations in the PRNP gene.
    Liberski PP; Barcikowska M; Cervenakova L; Bratosiewicz J; Marczewska M; Brown P; Gajdusek DC
    Acta Neuropathol; 1998 Oct; 96(4):425-30. PubMed ID: 9797009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular approaches to mechanisms of prion diseases.
    Bratosiewicz-Wasik J; Wasik TJ; Liberski PP
    Folia Neuropathol; 2004; 42 Suppl A():33-46. PubMed ID: 15449458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Creutzfeldt-Jakob disease and related disorders: etiopathogenetic aspects.
    Barbanti P; Pocchiari M
    Funct Neurol; 1997; 12(3-4):159-64. PubMed ID: 9218970
    [No Abstract]   [Full Text] [Related]  

  • 24. Dominantly inherited prion protein cerebral amyloidoses - a modern view of Gerstmann-Sträussler-Scheinker.
    Ghetti B; Piccardo P; Zanusso G
    Handb Clin Neurol; 2018; 153():243-269. PubMed ID: 29887140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in the histo-molecular pathology of human prion disease.
    Baiardi S; Rossi M; Capellari S; Parchi P
    Brain Pathol; 2019 Mar; 29(2):278-300. PubMed ID: 30588685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amyloid fibrils from the N-terminal prion protein fragment are infectious.
    Choi JK; Cali I; Surewicz K; Kong Q; Gambetti P; Surewicz WK
    Proc Natl Acad Sci U S A; 2016 Nov; 113(48):13851-13856. PubMed ID: 27849581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inherited prion disease with an alanine to valine mutation at codon 117 in the prion protein gene.
    Mallucci GR; Campbell TA; Dickinson A; Beck J; Holt M; Plant G; de Pauw KW; Hakin RN; Clarke CE; Howell S; Davies-Jones GA; Lawden M; Smith CM; Ince P; Ironside JW; Bridges LR; Dean A; Weeks I; Collinge J
    Brain; 1999 Oct; 122 ( Pt 10)():1823-37. PubMed ID: 10506086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transgenic mice recapitulate the phenotypic heterogeneity of genetic prion diseases without developing prion infectivity: Role of intracellular PrP retention in neurotoxicity.
    Chiesa R; Restelli E; Comerio L; Del Gallo F; Imeri L
    Prion; 2016 Mar; 10(2):93-102. PubMed ID: 26864450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prion diseases].
    Stoĭda NI; Zavalishin IA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(9 Pt 2):59-63. PubMed ID: 23235426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transmissible spongiform encephalopathies in humans.
    Belay ED
    Annu Rev Microbiol; 1999; 53():283-314. PubMed ID: 10547693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The molecular biology of the transmissible dementias.
    Owen F
    Mol Cell Biol Hum Dis Ser; 1994; 4():110-32. PubMed ID: 9439746
    [No Abstract]   [Full Text] [Related]  

  • 32. Genetic prion disease: the EUROCJD experience.
    Kovács GG; Puopolo M; Ladogana A; Pocchiari M; Budka H; van Duijn C; Collins SJ; Boyd A; Giulivi A; Coulthart M; Delasnerie-Laupretre N; Brandel JP; Zerr I; Kretzschmar HA; de Pedro-Cuesta J; Calero-Lara M; Glatzel M; Aguzzi A; Bishop M; Knight R; Belay G; Will R; Mitrova E;
    Hum Genet; 2005 Nov; 118(2):166-74. PubMed ID: 16187142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Gene mutation and pathology in human prion disease].
    Tashiro H; Doh-ura K
    No To Shinkei; 1997 Aug; 49(8):681-7. PubMed ID: 9282361
    [No Abstract]   [Full Text] [Related]  

  • 34. Prion diseases.
    Knight RS; Will RG
    J Neurol Neurosurg Psychiatry; 2004 Mar; 75 Suppl 1(Suppl 1):i36-42. PubMed ID: 14978149
    [No Abstract]   [Full Text] [Related]  

  • 35. Prion mutation D178N with highly variable disease onset and phenotype.
    Synofzik M; Bauer P; Schöls L
    J Neurol Neurosurg Psychiatry; 2009 Mar; 80(3):345-6. PubMed ID: 19228673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The epsilon isoform of 14-3-3 protein is a component of the prion protein amyloid deposits of Gerstmann-Sträussler-Scheinker disease.
    Di Fede G; Giaccone G; Limido L; Mangieri M; Suardi S; Puoti G; Morbin M; Mazzoleni G; Ghetti B; Tagliavini F
    J Neuropathol Exp Neurol; 2007 Feb; 66(2):124-30. PubMed ID: 17278997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The nosology of Creutzfeldt-Jakob disease and conditions related to the accumulation of PrPCJD in the nervous system.
    Richardson EP; Masters CL
    Brain Pathol; 1995 Jan; 5(1):33-41. PubMed ID: 7767489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Divergent clinical and neuropathological phenotype in a Gerstmann-Sträussler-Scheinker P102L family.
    Popova SN; Tarvainen I; Capellari S; Parchi P; Hannikainen P; Pirinen E; Haapasalo H; Alafuzoff I
    Acta Neurol Scand; 2012 Nov; 126(5):315-23. PubMed ID: 22211828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Gerstmann-Straüssler-Scheinker syndrome].
    Tranchant C; Warter JM
    Rev Neurol (Paris); 1998 Feb; 154(2):152-7. PubMed ID: 9773036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. De novo P102L mutation in a patient with Gerstmann-Sträussler-Scheinker disease.
    Kojović M; Glavač D; Ožek B; Zupan A; Popović M
    Eur J Neurol; 2011 Dec; 18(12):e152-3. PubMed ID: 22097954
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.